Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A fresh rally in fintech names has traders watching carefully. This article explores why fiserv stock just popped, wh...
Atlassian Corp. PLC posted stronger-than-expected Q1 results, but its stock has still tumbled. With 25 analysts stick...
When a top executive sells a sizable stake, investors pay attention. This article unpacks the CFO's 50,000-share move...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
A sharp dip can set off alarm bells, but it can also open doors. This article digs into why Qualcomm stock down 28% h...
Wells Fargo and Oppenheimer boosted Marvell targets this week, signaling rising confidence in AI infrastructure deman...
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
As whispers of an OpenAI IPO grow louder, investors must ask: is openai going public wrong for reasons that could der...
US stocks closed higher on Friday as a wave of fresh analyst calls lifted growth names such as Best Buy, Dell Technol...